NCT03939182 Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma Status COMPLETED Phase PHASE1
NCT03929822 Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis Status TERMINATED Phase N/A
NCT03922893 Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer Status RECRUITING Phase N/A
NCT03922880 Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma Status COMPLETED Phase PHASE1
NCT03909152 A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone Status COMPLETED Phase PHASE2
NCT03891602 DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement Status COMPLETED Phase N/A
NCT03885908 Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer Status TERMINATED Phase NA
NCT03879811 Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT03879798 DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03877250 Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies Status WITHDRAWN Phase N/A
NCT03877055 A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03866460 Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children Status COMPLETED Phase N/A
NCT03856086 Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients Status COMPLETED Phase NA
NCT03851458 Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT03843775 A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03843593 A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery Status COMPLETED Phase N/A
NCT03832569 Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03824483 Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) Status RECRUITING Phase PHASE2